Kerry Wentworth

General Counsel at NUVATION BIO INC.

Net worth: 253 340 $ as of 2026-05-30

53 year

61 connections

Health Technology

Consumer Services

Commercial Services

Profile

Kerry A. Wentworth is Director at Massachusetts Biotechnology Council since 2019 and Chief Regulatory Officer at Nuvation Bio, Inc. since 2022.
Former roles include Senior Director-Regulatory Affairs at Genelabs Technologies, Inc., Vice President-Clinical, Regulatory & Quality at Agenus, Inc. from 2013 to 2014, Chief Regulatory Officer at Flexion Therapeutics, Inc. from 2017 to 2021, and Head-Regulatory Affairs at Genzyme Corp.
Education includes undergraduate studies at the University of New Hampshire.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NUVATION BIO, INC. CLASS A 0.02%	2026-06-22	53,000 ( 0.02% )	253 340 $	2026-05-30

Kerry Wentworth active positions

Companies	Position	Start
NUVATION BIO INC.	General Counsel	2022-07-17
Massachusetts Biotechnology Council Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies	Director/Board Member	2019-03-31

All active positions of Kerry Wentworth

Former positions of Kerry Wentworth

Companies	Position	End
FLEXION THERAPEUTICS, INC.	General Counsel	2021-11-18
AGENUS INC.	Chief Tech/Sci/R&D Officer	2014-07-09
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	General Counsel	-
Genelabs Technologies, Inc. Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development	General Counsel	-

See the detail of Kerry Wentworth's experience

Training of Kerry Wentworth

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kerry Wentworth's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Genelabs Technologies, Inc. Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development	Health Technology
Agenus, Inc. Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions	Health Technology
University of New Hampshire University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Massachusetts Biotechnology Council Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies	Commercial Services
Nuvation Bio, Inc. Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates	Health Technology